Physician profile
Andersen Clervil
NPI 1558625814
$1,504.35
in general payments reported to CMS, 2019-2025
14 companies · $244 in 2025
The $244 reported for 2025 was more than what 80% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $181 · 2021: $233 · 2022: $216 · 2023: $184 · 2024: $176 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $389.59 | 2019-2024 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $220.08 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.28 | 2019-2023 | Jardiance |
| Pfizer INC. | $199.56 | 2019-2025 | |
| Scpharmaceuticals INC. | $129.45 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $101.13 | 2019-2022 | |
| Abbvie INC. | $71.16 | 2024-2025 | |
| Cumberland Pharmaceuticals, INC. | $53.48 | 2024-2025 | Vibativ |
| Smith+Nephew, INC. | $39.66 | 2019 | |
| Novo Nordisk INC | $24.39 | 2025 | Wegovy |
| Vifor Pharma, INC. | $20.97 | 2019 | |
| Heartflow, INC. | $20.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.92 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.21 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andersen Clervil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.